Large cohort study finds interstitial lung disease independently increases lung cancer risk across all major subtypes, even ...

Pune: Infantry soldier Tariq Aziz (30) is set to return to active duty after undergoing a bilateral lung transplant — the ...

Public pigeon feeding in Hyderabad, though seen as kindness, can cause severe lung diseases. Experts warn that droppings and ...

Liquidia Q2 sales hit $8.84 million after Yutrepia launch; PH-ILD study shows stable tolerability and improved walking ...

Pulmonary rehabilitation using minimal equipment achieved roughly the same benefits as when done with treadmills and other ...

Shiv Sena(UBT) on Wednesday supported the Supreme Court's orders upholding the Bombay High Court's stay on feeding pigeons ...

YUTREPIA surpasses 900 unique patient prescriptions and 550 patient starts within 11 weeks after approval to treat PAH and PH-ILDPositive interim data from ASCENT trial reinforces YUTREPIA's tolerabil ...

The FDA has granted accelerated approval to Hernexeos for the treatment of adults with unresectable or metastatic non-squamous NSCLC.

New trial results reveal that pembrolizumab and enfortumab vedotin significantly enhance survival rates for muscle-invasive ...

Shares of Liquidia hit a six-year high after the company reported higher-than-expected initial demand for its hypertension treatment Yutrepia and surging revenue in the second quarter. The stock rose ...

EMERYVILLE, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, reported its 2025 second quarter and year to date financial results and ...